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Flaviviruses, such as the dengue virus and the West Nile virus, are emerging arthropod-borne viruses that
represent an immense global health problem. Considerable progress has been made in understanding flavi-
virus structure and replication strategies, but only now are the complex molecular interactions between the
virus and host cell starting to be unraveled. In this Review, we discuss the ongoing efforts toward elucidating
the molecular mechanisms that allow flaviviruses to manipulate host cell functions for successful infection.
We draw attention to the importance of these studies in defining the pathogenesis of flaviviral diseases.Introduction
Flaviviruses are a group of more than 70 enveloped RNA viruses
that cause serious diseases in humans and animals. Most of
them are arthropod-borne viruses (arboviruses) and are trans-
mitted to vertebrate hosts by either mosquitoes or ticks (Gubler
et al., 2007). Several members of the flavivirus genus, such as the
dengue virus (DV), yellow fever virus (YFV), West Nile virus
(WNV), and Japanese encephalitis virus (JEV), are highly patho-
genic to humans and constitute major international health
problems (Gould and Solomon, 2008; Mackenzie et al., 2004).
These flaviviruses all share a similar genomic organization and
replication strategy, and yet cause a range of distinct clinical
diseases in humans. They can be broadly grouped into viruses
that have the capacity to cause vascular leak and haemorrhage,
including DV and YFV, and those that can cause encephalitis,
including WNV and JEV. Relatively few infected individuals
develop these severe clinical manifestations, and many are
asymptomatic or have an undifferentiated febrile illness.
Currently, it is not possible to predict who will develop severe
clinical illness, and our understanding of the molecular basis of
the pathogenesis of severe disease is inadequate.
Flaviviruses encode only ten proteins (Figure 1), and therefore
must exploit host cell machinery and functions in order to
complete their infectious cycle. Numerous host gene products
and pathways have recently been implicated in the replicative
cycle of flaviviruses (Table 1), but the biological relevance of
many of these interactions is not yet clear. In this Review, we
focus on important insights that have emerged into how flavivi-
ruses use and abuse a diverse array of host cell functions in order
to complete their infectious life cycle, and discuss their implica-
tions for pathogenesis. We place particular emphasis on DV and
WNV, and discuss how these pathogens interact with cellular
pathogen recognition receptors, stress response granules, and
membrane structures to promote crucial steps in their life cycle.
We highlight how new genome-wide screening technology is
revealing an increasingly complex picture of flavivirus-host cell
interactions. In addition to exploiting host cell factors to establish
infection successfully, flaviviruses have evolved specific mecha-318 Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc.nisms to counteract host antiviral defenses. We discuss the
specific interactions of virus-encoded proteins with human
innate immune pathways—in particular interferon and natural
killer cell responses—and build a picture of how these viruses
escape host defenses.
Flavivirus Life Cycle and Genomic Organization
Flaviviruses are lipid-enveloped viruses that contain a single-
stranded, positive sense RNA genome (Figure 1A). They are
introduced into the host by an infected vector during its blood
meal. Flaviviruses enter target cells by receptor-mediated endo-
cytosis and traffic to endosomes, where the acidic environment
triggers major conformational changes in their envelope glyco-
protein (E) protein that induce fusion of the viral and host cell
membranes (Figure 1B) (Bressanelli et al., 2004; Modis et al.,
2004). The released RNA encodes a polyprotein precursor of
approximately 3400 amino acids in length. This polypeptide is
co- and posttranslationally processed by host cell signalases
and the virus-encoded protease NS2B/NS3 to give rise to three
structural and seven nonstructural (NS) proteins (Figure 1A). The
structural proteins core (C), premembrane (prM), and E consti-
tute the viral particle while the NS proteins (NS1, NS2A, NS2B,
NS3, NS4A, NS4B, and NS5) are involved in viral RNA replica-
tion, virus assembly, and modulation of the host cell responses
(Lindenbach et al., 2007). After translation of input genomic
RNA, the RNA-dependent RNA polymerase (RdRp) NS5 copies
complementary minus-stand RNA from genomic RNA, which
serves as a template for the synthesis of new positive strand viral
RNA (Brinton, 2002). Flavivirus replication occurs on virus-
induced host cell membranes (Figure 1B). Such structures may
serve as a scaffold for anchoring the viral replication complexes,
which consist of viral RNA, viral proteins, and possibly host cell
factors (Mackenzie, 2005; Mackenzie et al., 1999). Immature,
noninfectious virions assemble within the endoplasmic reticulum
(ER), where viral RNA is complexed with the C protein and is
packaged into an ER-derived lipid bilayer containing hetero-
dimers of the prM and E proteins (Lorenz et al., 2003; Mackenzie
and Westaway, 2001). The prM protein acts as a scaffold that
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the cell (Li et al., 2008; Yu et al., 2008). After transport through the
host secretory pathway, virion maturation occurs in the trans-
Golgi network through the furin-mediated cleavage of the prM
to M (Li et al., 2008; Stadler et al., 1997; Yu et al., 2008). Mature
infectious particles are then released by exocytosis into the
extracellular medium (Figure 1B).
Use of C-Type Lectin Receptors by Flaviviruses
C-type lectin receptors (CLR) are host pathogen-recognition
receptors (PRR) that are specialized in sensing invading patho-
gens. Several members of this family are highly expressed on
myeloid cells, including monocytes macrophages and dendritic
cells (DCs), and thus play a central role in activating host
immune defenses (Robinson et al., 2006). A growing body of
evidence suggests that one of the CLRs, dendritic-cell specific
ICAM-3-grabbing nonintegrin (DC-SIGN, CD209) provides
a critical bridge between viral replication in insect vectors and
infection of the vertebrate host (Lozach et al., 2005; Navarro-
Sanchez et al., 2003; Tassaneetrithep et al., 2003). DC-SIGN is
a tetrameric C-type lectin specialized in pathogen capture and
antigen presentation and is constitutively expressed on DCs,
including those residing in the skin, the anatomical site of initial
infection following the bite of a flavivirus-infected mosquito (van
Kooyk and Geijtenbeek, 2003). DC-SIGN is an essential host cell
factor exploited by the four DV serotypes, as well as glycosy-
lated WNV strains, to enter into and infect productively immature
DCs (Davis et al., 2006; Lozach et al., 2005; Martina et al., 2008;
Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003). DC-
SIGN recognizes carbohydrate structures present on flavivirus
glycoproteins. The remarkable capacity of DC-SIGN to distin-
guish between high-mannose glycans typical of insect-derived
glycoproteins and the complex glycosylation of host-derived
proteins (Lozach et al., 2005; van Kooyk and Geijtenbeek,
2003) implies that flaviviruses have evolved an elegant strategy
to initiate infection of human cells by taking advantage of the
ligand specifity of this PRR. Indeed, this may represent
a universal mechanism evolved by arboviruses for transmission
to vertebrate hosts as suggested by recent data demonstrating
a similar entry mechanism for unrelated mosquito-borne viruses
such as Sindbis virus (an alphavirus) (Klimstra et al., 2003).
DC-SIGN-mediated infection is essential for DC maturation
(Lozach et al., 2005), which is a crucial event that allows DCs
to leave the skin and migrate to the lymph nodes, where they
present processed antigens to T cells and initiate adaptive
immune responses (Mellman and Steinman, 2001). It is likely,
therefore, that infection through DC-SIGN plays a critical role
in initial viral dissemination and pathogenesis. Identification of
a single nucleotide polymorphism in the DC-SIGN promoter
that is strongly associated with protection against dengue fever
strongly supports this concept of pathogenesis for DV (Sakun-
tabhai et al., 2005).
Another myeloid CLR, the mannose receptor (MR), has been
shown to bind the E protein of all four DV serotypes (Miller
et al., 2008). In primary macrophages, polyclonal antibody to
MR inhibits DV infection (Miller et al., 2008). However, these
data are insufficient to know whether MR is directly involved in
DV internalization. It is not known whether MR expression is
capable of rendering cells permissive to DV infection, whichhas been shown clearly for DC-SIGN (Lozach et al., 2005).
Furthermore, in vivo evidence, such as human genetic polymor-
phism associations, implicating MR in DV pathogenesis, remains
outstanding. A recent study that screened DV interactions with
CLRs identified C-type lectin domain family 5, member A
(CLEC5A, also known as MDL-1), as a new DV binding receptor
(Chen et al., 2008). CLEC5A is exclusively expressed on mono-
cytes and macrophages and associates with DAP12 to initiate
signal transduction (Bakker et al., 1999). In contrast to DC-
SIGN, CLEC5A does not promote viral entry. Instead, binding
of DV induces DAP12 phosphorylation and proinflammatory
cytokine production (Chen et al., 2008). Inhibition of the
CLEC5A-DV interaction was found to reduce secretion of
TNF-a from human macrophages and prevent vascular leak
and lethality in STAT-1-deficient mice (Chen et al., 2008). These
data suggest a new model of flavivirus pathogenesis in which the
virus activates a host signal transduction pathway by binding to
a cell surface PPR leading to a proinflammatory response that is
deleterious to the host. It is unclear why in the case of DV this
mechanism might provoke an excessive rather than protective
inflammatory response. It is important to investigate whether
this mechanism operates in other flavivirus infections, for
example WNV which causes a very different clinical disease
from DV in humans. A study of human CLEC5A genetic polymor-
phisms in patient cohorts could add considerable weight to the
in vivo relevance of this PRR to DV-induced lethal disease.
Genome-wide Screening of Cellular Factors Required
for Flavivirus Infection
Flaviviruses have evolved both overlapping and unique molec-
ular interactions with host cells that are likely to account for
differences in the pathogenesis of related flavivirus infections.
A recent genome-scale RNAi screen revealed that more than
300 host proteins affect the outcome of WNV infection (Krishnan
et al., 2008). These proteins are involved in crucial host cell
processes, including intracellular protein trafficking; signal trans-
duction; ion and molecular transport; and nucleic acid, protein,
and lipid metabolism. In keeping with previous data (Krishnan
et al., 2007; van der Schaar et al., 2008), this study confirmed
the importance of both the clathrin-mediated pathway for
endocytosis and host factors (e.g., vATPase) that regulate acid-
ification of endosomes (Krishnan et al., 2008). In addition, this
study revealed an unexpected role for a specific ubiquitin-ligase
(CBLL1) in WNV internalization and the potential importance of
components of the endoplasmic reticulum-associated protein
degradation (ERAD) pathway (which transports misfolded host
proteins to the proteasome for degradation) for WNV infection
(Krishnan et al., 2008). Interestingly, less than half of the genes
required for optimal WNV infection influenced the success of
DV infection. In particular, genes involved in carbohydrate and
lipid metabolism were overrepresented among genes specific
for WNV infection (Krishnan et al., 2008). We have recently
completed a genome-scale screening of host genes required
for YFV infection, and comparison with the data from the WNV
and DV screens will add further insight into the most important
flavivirus-host cell interactions that contribute to disease (A.A.,
unpublished data).
The screening approaches described above were designed to
identify cellular host factors associated with the early stages ofCell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc. 319
Cell Host & Microbe
ReviewFigure 1. Flavivirus Genome Structure and Replication Cycle
(A) Genome organization and viral protein functions. The single open reading frame encodes a polyprotein precursor that is co- and posttranslationally cleaved
into three structural proteins (in green) and seven nonstructural proteins (in red). Putative functions of these proteins during infection are described. Simplified320 Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc.
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ways important for later stages of the viral life cycle, such as
assembly and maturation. Up to now only two host factors, the
c-Yes and c-Src kinases, have been implicated in flavivirus
assembly (Chu and Yang, 2007; Hirsch et al., 2005). It is likely
that a myriad of other virus-host interactions are essential for
successful virus assembly and maturation and specific assays
need to be designed to exploit genome-wide RNAi screening to
decipher these molecular interactions. Although these genome-
wide approaches have tremendous potential, this technology is
young and we are only at the beginning of knowing how best
to exploit its scientific potential. Recent experience of three
RNAi screens of human genes involved in human immunodefi-
ciency virus (HIV) infection revealed that only a few genes were
identified consistently across three independently conducted
screens (Brass et al., 2008; Konig et al., 2008; Zhou et al.,
2008), highlighting the danger of overinterpreting the results
from a single screen. Further genome-wide screens of flavivirus
infections and their comparisons will be crucial to understanding
how both common and unique molecular interactions between
related flaviviruses and host cells account for differences in
pathogenesis.
Subversion of Stress Granule and Processing Body
Functions by Flaviviruses
Stress granules (SG) and processing bodies (PB) are ribonucleo-
protein granules found in the cytoplasm of cells in response to
many types of environmental stress such as oxidative stress,
heat shock, or viral infection. SG and PB are dynamically con-
nected to regulate the translation repression and decay of host
mRNA (Anderson and Kedersha, 2006). There is an emerging
consensus that flaviviruses manipulate SG and PB functions
for viral replication and pathogenesis (Figure 2). Pioneering
studies from Brinton’s group have revealed that TIA-1 and
TIAR, two RNA-binding proteins involved in SG assembly,
interact specifically with the 30SL of WNV complementary
minus-strand RNA, the site of initiation of RNA synthesis
(Li et al., 2002). TIAR is an essential host cellular factor exploited
by WNV for RNA amplification since WNV infection is greatly
diminished in TIAR knockout fibroblasts (Li et al., 2002). During
WNV infection, both TIAR and TIA are sequestered at viral repli-
cation foci and consequently SG formation is inhibited (Emara
and Brinton, 2007). Interestingly, a similar mechanism has
been described for DV (Emara and Brinton, 2007), suggesting
that interference with SG assembly may represent a common
strategy used by flaviviruses to prevent the inhibition of viral
mRNA translation and to enhance RNA synthesis. Whether
TIA-1 and TIAR bind to the 30SL of other flaviviruses and whether
they recruit viral or additional SG factors to facilitate genomic
RNA synthesis remain to be determined.Recent work has shown that several members of the flavivirus
genus subvert the 50-30 mRNA decay pathway that takes place in
PB to generate a unique non coding (nc) RNA of 0.3–0.5 kb that is
essential for their pathogenicity (Pijlman et al., 2008). This viral
ncRNA (also called sfRNA for subgenomic flavivirus RNA) is
the result of incomplete degradation of genomic viral RNA by
50-30 exoribonuclease XRN1, one key component of PB (Pijlman
et al., 2008). SfRNA was found in cells infected by all members of
the flavivirus genus that were studied, but not in cells infected
with a pestivirus, hepacivirus, or alphavirus (Pijlman et al.,
2008). A highly conserved RNA structure located at the begin-
ning of the 30UTR (SLII) renders sfRNA resistant to the ribonucle-
ases present in infected cells. An exciting aspect of this study is
that sfRNA production seems to be essential for flavivirus-
induced cytopathicity and play a crucial role in determining viral
pathogenesis (Pijlman et al., 2008). Mutations or deletions within
the 30UTR region of the flavivirus genome that inhibit sfRNA
production have little impact on the efficiency of viral RNA ampli-
fication. However, viruses that do not produce sfRNA show
marked attenuation of their cytopathic effect when compared
with wild-type virus, and are less pathogenic when injected to
mice. Important questions raised by this study are how sfRNA
regulates the flavivirus life cycle and how this viral ncRNA
contributes to virus pathogenesis. One possibility is that sfRNA
production modulates host antiviral responses by antagonizing
or inactivating cellular RNA sensors that orchestrate innate
immunity, such as Toll-like receptor 3, RIG-I, and MDA5. Recent
studies have indicated that PB contain RNA-induced silencing
complexes (RISC) and are thought to be integrated with the
microRNA (miRNA)-induced translational silencing pathways
(Liu et al., 2005a). A speculative model would be that sfRNA
acts as a miRNA decoy, inhibiting miRNA binding to genomic
RNA and thus preventing viral RNA degradation. Importantly,
sfRNA production alone does not lead to cytopathicity, implying
that this mechanism operates in the context of viral infection.
Whether it requires the participation of a specific viral proteins
and/or additional components of PB remains to be investigated.
Co-opting Host Cell Membrane Structures
and Cholesterol Metabolism for Virus Replication
and Immune Evasion
Like several positive stranded RNA viruses, flaviviruses manipu-
late host cell membranes in order to create an optimal microenvi-
ronment for replication complex assembly and RNA amplification
(Miller and Krijnse-Locker, 2008). Pioneering studies done on
Kunjin virus (KUNV), the Australian variant of WNV, revealed
that flaviviruses cause dramatic rearrangement and induction
of unique membrane structures within the perinuclear region of
infected cells (Mackenzie et al., 1996, 1999; Westaway et al.,
1997). A characteristic large cluster of vesicle packets (VP), whichRNA secondary and tertiary structures within the 50 and 30 untranslated regions (UTRs) are indicated. aa, amino acids; C, capsid protein; CS, cyclization
sequence; E, envelope; M, membrane; RdRp, RNA-dependent RNA-polymerase; UAR, upstream AUG regions; VR, variable region; SL, stem loop.
(B) Flavivirus infectious life cycle. Flaviviruses are internalized by receptor-mediated endocytosis (1) and trafficked to early endosomes, where the acidic envi-
ronment induces fusion (2) between the virus and the host membrane resulting in genome release (3). Translation of viral RNA is followed by processing of the
resulting polyprotein by host and virus-encoded proteins (4). The cleavage sites and topology of structural (in green) and nonstructural (NS) (in red) proteins at the
endoplasmic reticulum (ER) membrane are illustrated schematically. Following translation, a replication complex is assembled and associated to virus-induced
membranes where viral replication takes place (5). The replication complex starts to transcribe the RNA (+) template into RNA (), which then serves as template
for new RNA (+) synthesis. Progeny RNA (+) strands can either initiate a new translation cycle or be assembled into virions (6). Packaging occurs on the surface of
the ER, followed by budding of the structural proteins and newly synthesized RNA into the lumen of the ER. The resultant immature virions are transported to the
trans-Golgi where furin-mediated cleavage of prM to M generates mature infectious particles (7) that are released by exocytosis (8).Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc. 321
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Phase Host Proteins Function Viral Function Viral Partner Reference
Entry and
signaling
Heparan sulfates Cell growth factor and
differentiation;extracellular
matrix
Attachment factor E protein (Chen et al., 1997)
DC-SIGN (CD209)L-SIGN
(CD209L)
Cell adhesion;antigen
presentation
Attachment factor E protein (Navarro-Sanchez et al.,
2003; Tassaneetrithep et al.,
2003; Davis et al., 2006)
Mannose receptor Antigen internalization Binding E protein (Miller et al., 2008)
avb3 integrin Cell adhesion Internalization; signaling? E protein (Chu and Ng, 2004)
CLEC5A Inflammatory response Binding; signaling E protein (Chen et al., 2008)
CBLL1 Ubiquitin ligase Endocytosis ? (Krishnan et al., 2008)
Viral
replication
MCT4 Plasma membrane
transporter of
monocarboxylic acids
Delay transition
into replication
? (Krishnan et al., 2008)
YB-1 Translation, transcription,
mRNA stability
Inhibit viral translation;
antiviral response?
30(+) SL (Paranjape and Harris, 2007)
TIA-1 and TIAR Stress granules assembly Stress granules inhibition 30(-) SL (Emara and Brinton, 2007)
EF-1a Translation elongation
factor
Minus-strand RNA
synthesis
30(+) SL (Blackwell and Brinton, 1997)
3-Hydroxy-methylglutaryl-
CoA reductase
Cholesterol biosynthesis Virus-induced membranes NS4A? (Mackenzie et al., 2007)
Nuclear receptor
binding protein
ER-Golgi trafficking Virus-induced membranes NS3 (Chua et al., 2004)
Importin a/b Intracellular transporters RdRp nuclear import NS5 (Pryor et al., 2007)
Nucleolar
phosphoprotein B23
Histone chaperone
activity; transcriptional
regulation
JEV C protein nuclear
import
C protein (Tsuda et al., 2006)
Ubc9 SUMOylation ? E protein (Chiu et al., 2007)
Jab1 COP9 signalosome Virus degradation;
nuclear export
C protein (Oh et al., 2006)
Assembly
and egress
TSG 101 Multivesicular body
biogenesis
Virus-induced convoluted
membranes
NS3 (Chiou et al., 2003)
c-Src Tyrosine kinase:
signal transduction
Budding of the
nucleocapsid into
the ER lumen
? (Chu and Yang, 2007)
c-Yes Virus trafficking through
the secretory pathway
No (Hirsch et al., 2005)
Vacuolar ATPase Acidification
of intracellular organelles
Virus entry; egress
and secretion
prM (Duan et al., 2008)
Furin Convertase Cleavage of the prM
to M, virus maturation
prM (Stadler et al., 1997)
Immune
evasion and
pathogenesis
Scribble protein Cell-to-cell contacts IFN response antagonist NS5 (Werme et al., 2008)
DEAD-box RNA
helicase DDX42
RNA helicase;
antiviral response
Prevent virus
induced-antagonism
of IFN response
NS4A (Lin et al., 2008)
hnRNP C1/C2 mRNA biogenesis, RNA
binding
? NS1 (Noisakran et al., 2008)
Factor H Complement activation Prevent complement
dependent lysis of infected
cells
NS1 (Chung et al., 2006)
Clusterin Inhibitor of the terminal
pathway of the
complement system
Plasma leakage? NS1 (Kurosu et al., 2007)322 Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc.
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and Processing Bodies by Flaviviruses
Stress granules (SG) and processing bodies (PB) are cyto-
plasmic ribonucleoprotein granules that regulate translation
and decay of messenger RNA. (A) Flaviviruses interfere with
SG assembly by recruiting the SG components TIA-1 and
TIA-R at the site of viral replication. TIA-1 and TIAR interact
with the 30 stem loop (SL) of flavivirus-minus strand RNA and
increase the rate of viral RNA synthesis.
(B) During infection, genomic RNA (gRNA) is also targeted to
the cellular mRNA degradation pathway within PB. Viral RNA
is decapped and degradated by the 50-30 exonuclease XRN1
(1). A conserved RNA structure (SLII) located at the beginning
of the 30UTR of the gRNA blocks complete degradation of the
viral RNA by XRN1 (2), leading to the production of a subge-
nomic flavivirus RNA (sfRNA) of 0.3–0.5kb length (3). SfRNA
plays an essential role in virus-induced cytophatic effect and
pathogenesis through cellular mechanisms that remain to be
discovered.are spherical membranes structures 50–150 nm in diameter, is
observed in cells infected with flaviviruses (Mackenzie, 2005;
Mackenzie et al., 1999). In addition, convoluted membranes
and paracrystalline structures, which are ordered membranes
adjacent to VP, have been detected at later stages of infection
and are thought to be the site of viral polyprotein processing
(Mackenzie, 2005). Immunolabeling studies have shown that
several viral NS proteins, as well as dsRNA (an obligatory inter-
mediate of RNA+ virus replication), localize within VP (Mackenzie,
2005; Westaway et al., 1997). A recent electron tomography (ET)
study of DV-induced membranes revealed unambiguously that
VP are invaginations of ER membranes that retain an open
connection to the surrounding cytoplasm via a pore (Welsch
et al., 2009). The inside of the vesicles is likely the site of viral
RNA replication. The pore may be involved in the import of host
factors and nucleotides required for efficient RNA replication
and the export of the newly synthesized viral genomes (Welsch
et al., 2009). ET has also revealed that flavivirus budding occurs
on distinct ER membranes that are apposed to vesicle pores
(Welsch et al., 2009). Topologically, this is the only model that
can truly make sense with respect to flavivirus replication and
assembly. The viral protein NS4A is thought to play an essential
role in the induction of the invaginations of the ER membrane
(Miller et al., 2007; Roosendaal et al., 2006). However, further
studies are required to decipher the molecular mechanisms by
which NS4A induces these membrane changes, and to investi-
gate whether other viral NS proteins and/or host factors play
a role.
The reasons for flaviviruses to wrap their replicative machinery
within such structures are also unclear. One possibility is that
such structures may concentrate viral components to improve
the efficiency of viral replication and serve as a scaffold for
anchoring the viral replication complex (Figure 3). In addition,
VP may also hide flavivirus RNA from host cellular surveillance
and particularly those that are activated by dsRNA intermediates
that arise during RNA synthesis (Figure 3). The first hint of
a connection between flavivirus-induced membranes and
immune evasion comes from the observation that WNV-induced
cytoplasmic membrane structures provide partial protectionagainst the interferon-induced antiviral MxA protein (Hoenen
et al., 2007). Another recent study indicates that manipulation
of host cellular pathways involved in cholesterol biosynthesis
may represent a strategy evolved by WNV to facilitate viral
replication and evade cellular antiviral responses (Mackenzie
et al., 2007). WNV infection leads to the redistribution of cellular
cholesterol and the cholesterol-synthesizing enzyme hydroxy-
methylglutaryl-CoA reductase (HMGCR) to establish the
membrane platforms required for efficient replication (Macken-
zie et al., 2007). This appears to be essential for WNV replication
since both RNAi-mediated knockdown of the HMGCR gene and
cholesterol-modulating drugs strongly inhibit RNA amplification
(Mackenzie et al., 2007). HMGCR has been shown to localize
within proliferated reticulum membranes in infected cells,
although its role in the induction of virus-induced membrane
platforms is unclear. Whether HMGCR is directly involved in
this process or plays a synergistic role with NS4A remain to be
determined. A major consequence of virus-induced redistribu-
tion of cellular cholesterol is the loss of lipid raft function and
inhibition of the interferon signaling pathway. In WNV-infected
cells, STAT-1 phosphorylation and translocation to the nucleus
in response to IFN-a is reduced, and this can be partially over-
come by exogenous addition of cholesterol (Mackenzie et al.,
2007). The importance of this immune evasion strategy to flavivi-
rus pathogenesis in general remains to be elucidated. It will be of
significant interest to investigate whether administration of
compounds that target cholesterol biosynthesis or inhibit
HMGCR can protect mice against the development of severe
WNV infection, and to study the outcome of WNV infection in
mice lacking genes that regulate cholesterol biosynthesis.
Inhibition of Interferon-Mediated Responses
by Flavivirus Proteins
The type I IFN (IFN-a/b) response to viral infection induces
a cellular antiviral state, which plays a major role in limiting the
early replication and spread of many viruses. The ability to
counter the human type I IFN response is probably crucial for
viruses to establish infection successfully in man, and consider-
able advances have been made in the last few years towardCell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc. 323
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Virus Replication and Immune Evasion
West Nile and several other flaviviruses induce the forma-
tion vesicle packets (VP), which are highly complex
ER-derived-membrane structures that are enriched in viral
double-stranded (ds)RNA and viral NS proteins. To create
such membrane platforms required for efficient RNA
synthesis, West Nile virus upregulates the cholesterol-
synthesizing enzyme HMGCR and induces host cell
cholesterol biosynthesis at the site of virus replication. In
addition, WNV redistributes cholesterol from the plasma
membrane to VP, which results in the disruption of lipid
raft domains and inhibition of the IFN-regulated Jak/Stat
signaling pathway. Sequestration of viral dsRNA interme-
diates within cholesterol rich-membrane structures may
allow the virus to avoid recognition by cytoplasmic viral
RNA sensors and escape host antiviral defenses.understanding the specific IFN-antagonistic mechanisms
evolved by flaviviruses. One strategy utilized by WNV is to delay
induction of type I IFN by infected cells, which may enhance
initial infection within the vertebrate host (Fredericksen et al.,
2004). It is possible that the initial rate of WNV replication is
simply below a threshold necessary to activate cellular PRRs
such as RIG-I and TLR3 that initiate production of type I IFN
(Fredericksen et al., 2004). However, more recent data suggests
that inhibition of PRR is a more active function of virus-encoded
proteins. WNV NS1 has recently been shown to block TLR3-
mediated signaling and induction of the antiviral state (Wilson
et al., 2008). WNV E protein is thought to interfere with ubiquiti-
nation of RIP-1, a signaling kinase common to both RIG-I and
TLR3 pathways, and blunt responses to viral RNA (Arjona
et al., 2007). Only mosquito cell-derived WNV E protein exerted
this effect, suggesting a possible immune evasion mechanism
during initial infection of the vertebrate host (Arjona et al., 2007).
Although inhibition of induction of the IFN response may be
important in the early stages of flavivirus infection in the verte-
brate host, it appears that later replication and viral dissemina-
tion occurs even in the presence of high levels of circulating
IFN (Kurane et al., 1993). Once cellular infection has been estab-
lished, flavivirus replication is remarkably resistant to the antiviral
effect of IFN (Diamond et al., 2000). Global downregulation of
the IFN response through inhibition of IFN-mediated signal trans-
duction by flavivirus NS proteins has emerged as a key mecha-
nism of innate immune evasion (Figure 4). DV and WNV NS
proteins NS2A, NS4A, and NS4B have all been implicated in
IFN inhibition (Liu et al., 2005b; Munoz-Jordan et al., 2003).
Expression of these NS proteins in cell lines was shown to
reduce phosphorylation of a key component of the type I IFN
signal transduction pathway, STAT1. This suggests that these
NS proteins may share the ability to inhibit early events in type
I IFN signaling, but further studies are required to understand
the molecular mechanism and investigate the biological rele-
vance of these observations. Studies on tick-borne flaviviruses,324 Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc.tick-borne encephalitis virus, and Langat virus reveal that NS5
protein is an IFN antagonist that acts by inhibiting early phos-
phorylation events in the IFN signal transduction pathway (Best
et al., 2005; Park et al., 2007). Recruitment of NS5 to the plasma
membrane through its interaction with a host factor, scribble,
appears to be essential for IFN antagonism (Werme et al.,
2008), and it is possible that plasma-membrane localized NS5
interacts directly with IFN receptors to inhibit phosphorylation
of the receptor-associated kinases Jak1 and Tyk2 (Best et al.,
2005). A similar strategy may be utilized by JEV, a more distantly
related mosquito-borne flavivirus, where again NS5 appears to
block Tyk2 phosphorylation (Lin et al., 2006). WNV infection
also inhibits Jak1 and Tyk2 phosphorylation (Guo et al., 2005).
DV has also been shown in one study to block Tyk2 phosphory-
lation (Ho et al., 2005), although the main target for inhibition of
type I IFN signal transduction may be STAT2, a downstream
cytoplasmic component of the signaling cascade (Jones et al.,
2005). We have recently found that DV NS5 is also potent IFN
antagonist (M.M. and M.J., unpublished data). Thus, NS5 may
be a common IFN antagonist that plays a crucial role in flavivirus
pathogenesis in addition to its central function in viral RNA repli-
cation. Taken together, these data suggest that both tick- and
mosquito-borne flaviviruses may have evolved diverse mecha-
nisms of immune evasion through inhibition of early events in
the IFN signal transduction pathway. Keller et al. (2006) demon-
strated that an avirulent strain (MAD78) of WNV was highly sensi-
tive in vitro to the antiviral effects of IFN, unlike pathogenic
strains which inhibit IFN signaling (Keller et al., 2006). Further-
more, the virulence of the MAD78 was unmasked in IFN receptor
deficient mice, confirming the importance of IFN antagonism as
a determinant of viral pathogenesis. Detailed understanding of
the molecular basis of IFN antagonism by flaviviruses in the
future will enable reverse genetic engineering of viruses that
vary in their sensitivity to IFN. These viruses could provide crucial
insights into disease pathogenesis and may form the basis for
rationally attenuated vaccine candidates.
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ReviewFigure 4. Type I Interferon Signal
Transduction Pathway and Putative
Inhibition by Flaviviruses
Virus infection classically induces secretion
of type 1 interferons (IFN-1), which bind to cell-
surface IFN-a receptors (IFNAR, comprising
IFNAR1 and IFNAR2 subunits) on infected and
nearby cells. Binding of IFN-1 to IFNAR leads to
activation of Jak1 and Tyk2 kinases via tyrosine
phosphorylation. In turn, STAT2 and then STAT1
are phosphorylated and form heterodimers, which
then associate with IRF-9 to form ISGF3
complexes. ISGF3 complexes translocate to the
nucleus and initiate transcription of interferon-
stimulated genes by binding interferon-stimulated
response elements (ISREs), leading to trans-
criptional upregulation of hundreds of cellular
genes and induction of an antiviral state. Proposed
sites of inhibition by flaviviruses are shown in the
boxes.Evasion of Natural Killer Cell Cytoxicity
Natural killer (NK) cells, an important component of cellular
innate immunity, can recognize and kill virus-infected cells
(Lanier, 2008). NK cells display both activating and inhibitory
receptors that recognize different ligands. The cytolytic activity
of NK cells is determined by the integration of these opposing
signals (Lopez-Botet et al., 1999). One important signal is deter-
mined by engagement of NK inhibitory receptors with the host
cell’s major histocompatibility complex class I (MHC-I) mole-
cules. Many viruses downregulate MHC-I on the cell surface in
order to evade cytotoxic T cell (CTL) responses, but the reduc-
tion in MHC-I results in activation of NK cell killing (Lanier,
2008). In response to flavivirus infection, early activation of NK
cells has been observed but this is transient (Azeredo et al.,
2006; Shresta et al., 2004). Unlike many other viruses, flavivi-
ruses appear to increase MHC-I expression on infected cells
(Mullbacher and Lobigs, 1995). WNV infection increases cellular
MHC-I expression by enhancing the activity of the transporters
associated with antigen processing (TAP) and by NF-kB-depen-
dent transcriptional activation of MHC-I genes (Cheng et al.,
2004). Upregulation of MHC-I molecules can be observed up
to 96 hr after infection, and it is not due to the effect of IFN or
any other cytokines, suggesting the direct involvement of some
viral components. Lobigs and colleagues suggested that upre-
gulation of surface MHC-I molecules seen in response to DV
infection might be an incidental consequence of viral assembly
rather than a specific mechanism of immune evasion, with
uncleaved viral C-prM protein precursor (see Figure 1A) respon-
sible for the phenomenon (Lobigs et al., 2004). However, MHC-I
upregulation can be observed in cells stably expressing DV repli-
cons, which only express DV nonstructural proteins (Hershkovitz
et al., 2008). It is not yet resolved whether MHC-I upregulation is
a response to a particular viral protein or viral RNA replication
more generally. Irrespective of the mechanism, recent evidence
suggests that MHC-I upregulation does have potentially impor-
tant functional consequences, inhibiting NK cytolytic activity
(Hershkovitz et al., 2008). Even moderate enhancement ofMHC-I expression results in significant inhibition of NK cytolytic
activity. Flavivirus-induced aggregation of MHC-I molecules on
the surface of target cells appears to result in greatly enhanced
engagement by NK inhibitory receptors (Hershkovitz et al.,
2008). As with WNV, both enhanced TAP activity and transcrip-
tional upregulation of MHC-I have been described with DV,
depending on the specific cell lines tested (Hershkovitz et al.,
2008). This last observation suggests that overexpression of
MHC-I molecules may involve more than one mechanism, and
implies that it may represent an important evolutionary attribute.
It is intriguing that flaviviruses actually upregulate MHC-I when
under normal circumstances basal levels of expression are suffi-
cient to protect cells from NK killing. It is possible that flavivirus
infections result in cell surface expression of a cellular or viral
factor that interacts with NK activating receptors, and increased
MHC-I expression counteracts the activation signals to NK cells.
Increased MHC-I expression may result in enhanced CTL
killing at a later stage of infection, but this is probably not a signif-
icant evolutionary disadvantage for flaviviruses. The evolution
of arthropod-borne flaviviruses has probably been more affected
by the selective pressure of innate rather than adaptive immu-
nity. Flaviviruses such as DV, WNV, and JEV do not establish
persistent viral infection in the vertebrate host; infection of their
arthropod vectors, which is essential for propagation of the virus,
must occur during the short viremic period (Monath, 1994). This
enforces a selective pressure toward viruses that are capable of
replicating rapidly and reaching high titers of virus in human
blood, increasing the probability of transmission to its arthropod
vector and hence evolutionary survival. As a consequence,
subsequent engagement of effective adaptive immune
responses may not exert significant evolutionary pressure on
flaviviruses if contemporaneously their life cycle is continuing
within infected arbovirus vectors. The emerging data described
above demonstrating that flaviviruses inhibit two major arms of
the innate immune system, the IFN system, and NK cells,
perhaps emphasizes the evolutionary importance of innate
immune subversion to these viruses.Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc. 325
Cell Host & Microbe
ReviewConcluding Remarks
As illustrated in this Review, the study of flavivirus-host cell
interactions has advanced greatly in recent years leading to
the identification of several key cellular molecules that are poten-
tially important in disease progression and pathogenesis. The
future challenge will be to unravel the function of these cellular
molecules in the proper host context. Moving from cell culture-
based systems to relevant animal disease models will be a crucial
step to understanding severe flavivirus diseases. Different flavi-
viruses have evolved to utilize different vertebrate amplification
hosts (for example birds for WNV, humans for DV), which may
account for important differences in the molecular interactions
with human cell. Further comparative studies similar to those
described by Krishnan et al. (2008) using different, medically
important flaviviruses may unlock crucial mechanisms of
disease pathogenesis. We will then begin to understand at
a molecular level why these viruses cause a range of different
diseases in humans. Finally, studies on the immunobiology of
DV and WNV have revealed that these pathogens have devel-
oped several elegant mechanisms to counteract host innate
immune responses. An in-depth understanding of the molecular
mechanisms involved and the identification of novel immune
evasion strategies will undoubtedly contribute to the develop-
ment of effective vaccines and therapeutics to combat flavivi-
rus-mediated diseases.
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